.jpg)
March 8, 2024 – Backstop Neural, a pioneer in the development of the world’s first thin film-based spinal cord stimulator (SCS) paddle lead, is delighted to announce it has been selected to present at LSI USA '24, a premier event dedicated to driving forward the landscape of medtech innovation. Set to take place at the Monarch Beach Resort, Waldorf Astoria in Dana Point, California, from March 18-22, 2024, LSI USA '24 brings together visionaries, investors, and leaders in the field to propel transformative healthcare solutions.
The LSI USA '24 event was conceived with a singular vision: create forums for the leaders building, financing and scaling medtech innovation to challenge convention and catalyze better healthcare for all. Over the years, this vision has flourished into a global ecosystem comprising curated events across the USA and Europe, immersive content and digital media, and a vibrant community dedicated to fostering innovation that enhances and saves lives.
In 2022, the LSI ecosystem played a pivotal role in accelerating startups from their early stages to successful exits, facilitating Emerging Medtech Summit Alumni in securing over $1.45 billion in capital, and empowering strategic decision-making at global corporations ranging from industry giants like Medtronic to renowned consulting firms like McKinsey & Co. Regardless of size or stage, LSI stands as a trusted partner for medtech innovators worldwide, providing invaluable support and resources to drive their initiatives forward.
BackStop Neural is honored to have been selected as a presenter at LSI USA '24, joining a prestigious lineup of innovators, investors, and industry leaders who are shaping the future of healthcare. This presents an exceptional opportunity for BackStop Neural to showcase its groundbreaking thin film-based spinal cord stimulation leads and engage with key stakeholders in the medtech ecosystem.
"We are thrilled to be chosen as a presenter at LSI USA '24," said BackStop Neural CEO Connie Manz. "This event epitomizes the spirit of innovation and collaboration that drives progress in the medtech industry. We look forward to sharing our vision and insights, as well as forging meaningful connections with fellow innovators, investors, and industry experts."
BackStop Neural extends its gratitude to the organizers of LSI USA '24 for this prestigious opportunity and eagerly anticipates contributing to the dialogue surrounding medtech innovation at the event.
For more information about BackStop Neural and its groundbreaking electrode arrays, please visit www.backstopneural.com.
About BackStop Neural
BackStop Neural is a pioneering medical device company that specializes in developing advanced spinal cord stimulation solutions for individuals suffering from chronic pain. Through proprietary materials and neurostimulation technology, the company strives to provide patients with a renewed sense of hope and freedom from debilitating conditions. With a team of dedicated experts and a patient-centered approach, BackStop Neural aims to transform the landscape of neurology and elevate the standard of patient care.
For media inquiries, please contact:
Kial Gramley, Chief Product Officer
(956) 219-6752
kial.gramley@backstopneural.com
コメント